Skip to main content

Table 1 Patients' characteristics

From: Gout impacts on function and health-related quality of life beyond associated risk factors and medical conditions: results from the KING observational study of the Italian Society for Rheumatology (SIR)

Characteristic  
Sex (male) 403/446 (90.4)
Age (years) 63.9 (11.6)
Employment  
   Employed 137 (30.7)
   Unemployed 28 (6.3)
   Retired 226 (59.6)
   Unknown/not declared 15 (3.4)
Education  
   No or primary 158 (35.9)
   Secondary 121 (27.5)
   Upper secondary 123 (27.9)
   Tertiary 38 (8.6)
Current smokers 72/444 (16.2)
Body mass index 28.0 (4.1)
High alcohol consumers 160 (36.4)
Comorbidities 3 (1 to 4)
   Hypertension 313 (70.3)
   Renal failure 73 (16.4)
   Osteoarthritis 249 (55.9)
   Cardiovascular disorders 119 (26.8)
   Diabetes 64 (14.4)
   Liver disorders 36 (8.1)
   Neoplasms 28 (6.29)
Sangha comorbidity index (0 to 36) 4 (2 to 7)
Fulfils preliminary ACR criteria 411/445 (92.4)
Disease duration (years) 3.8 (1.5 to 10.1)
Joint involvement  
   Monoarticular (1 joint) 95(21.5)
   Oligoarticular (2 to 4 joints) 264 (59.7)
   Polyarticular (>4 joints) 83 (18.8)
Swollen joints (0 to 66) 0 (0 to 1)
Tender joints (0 to 68) 1 (0 to 3)
Presence of tophia 87 (19.9)
Number of flares (12 months) 1 (0 to 3)
Flare (previous month) 132 (29.9)
Serum urate level (mg/dl)b 6.3 (1.7)
Previous corticosteroids 125 (28.0)
Current NSAIDs or colchicine 189 (42.4)
Allopurinol 303 (67.9)
Febuxostat 60 (13.4)
  1. Data presented as n (%), mean (standard deviation) or median (interquartile range). ACR, American College of Rheumatology; NSAID, nonsteroidal anti-inflammatory drug. Data available for a437 subjects and b410 subjects.